Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
16.18
+0.01 (0.06%)
At close: Mar 28, 2025, 4:00 PM
16.21
+0.03 (0.17%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Avantor Revenue
In the year 2024, Avantor had annual revenue of $6.78B, down -2.64%. Avantor had revenue of $1.69B in the quarter ending December 31, 2024, a decrease of -2.10%.
Revenue (ttm)
$6.78B
Revenue Growth
-2.64%
P/S Ratio
1.62
Revenue / Employee
$502,489
Employees
13,500
Market Cap
11.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.78B | -183.60M | -2.64% |
Dec 31, 2023 | 6.97B | -545.20M | -7.26% |
Dec 31, 2022 | 7.51B | 126.30M | 1.71% |
Dec 31, 2021 | 7.39B | 992.50M | 15.52% |
Dec 31, 2020 | 6.39B | 353.30M | 5.85% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
AVTR News
- 23 hours ago - Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025 - PRNewsWire
- 12 days ago - Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025 - PRNewsWire
- 5 weeks ago - Avantor® to Present at TD Cowen's 45th Annual Health Care Conference - PRNewsWire
- 5 weeks ago - Silq Technologies Corp. and NuSil Technology LLC Announce Collaboration Agreement to Drive Broad-based Adoption of Silq's Novel Surface Treatment Technology - Business Wire
- 7 weeks ago - Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025 - Benzinga
- 7 weeks ago - Avantor® Reports Fourth Quarter and Full Year 2024 Results - PRNewsWire
- 7 weeks ago - TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe - Business Wire